Join the Diabetes, Type 1 group to help and get support from people like you.
Diabetes, Type 1 News
Related terms: Insulin Dependent Diabetes, Juvenile onset diabetes, Type 1 Diabetes, Type One, Type 1, Type 1 Diabetes Mellitus
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
MONDAY, Sept. 29, 2025 – Antithymocyte globulin (ATG) 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes, according to a study published online Sept. ...
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
MONDAY, Sept. 29, 2025 – Two-year follow-up shows a loss of therapeutic benefit when baricitinib treatment is stopped in type 1 diabetes (T1D), according to a study presented at the annual meeting...
Clinical Practice Guidelines Issued for Diabetes Distress
THURSDAY, Sept. 25, 2025 – The first clinical practice guidelines on assessment and management of diabetes distress among adults were presented at the annual meeting of the European Association for...
Baricitinib Effective In Slowing Type 1 Diabetes Progression
TUESDAY, Sept. 23, 2025 — A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib safely preserved the b...
Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment
MONDAY, Sept. 15, 2025 – In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study published online Sept. 8...
Access to Modern Technologies, Insulin Affects HbA1c Levels in Pediatric Type 1 Diabetes
WEDNESDAY, Sept. 3, 2025 – For children with type 1 diabetes (T1D), glycated hemoglobin (HbA1c) levels are associated with accessibility of modern diabetes technologies and insulin, according to a...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 – Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic groups, according to...
Autoimmune Diseases Linked to Digestive System Cancers
FRIDAY, Aug. 15, 2025 – Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of eClinicalMedicine. Julia Reizner, from the...
Advanced Tech Making Type 1 Diabetes More Manageable
THURSDAY, Aug. 14, 2025 — Advanced technology has boosted the ability of children and adults to manage their type 1 diabetes, a new study says. The number of kids under 18 who’ve achieved optimal con...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
THURSDAY, Aug. 14, 2025 – From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D), according to a study...
GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
TUESDAY, Aug. 12, 2025 – For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic...
New Subtype of Diabetes Identified in Sub-Saharan Africans, Black Americans
FRIDAY, Aug. 1, 2025 – A new diabetes subtype has been identified in Sub-Saharan Africans and Black Americans, according to a study published online July 21 in The Lancet Diabetes and Endocrinology....
Patients With Diabetes More Likely to Experience Adverse Financial Outcomes
MONDAY, July 28, 2025 – Patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes, according to a study published online July...
'Weekend Warrior' Workouts Reduce Diabetics' Risk Of Death
WEDNESDAY, July 23, 2025 — A “weekend warrior” exercise schedule can lower diabetics’ risk of early death, a new study says. People with diabetes who get all their recommended weekly exercise in one o...
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians, allied health...
Further information
Related condition support groups
Related drug support groups
Lantus, Lantus Solostar, Humalog, Novolog, insulin glargine, insulin lispro, Tresiba, Levemir, insulin degludec, Humulin N